|
|
|
Volumn 14, Issue , 1998, Pages 228-231
|
|
ITDI is the preferred treatment for iron supplementation in rHuEpo-treated anemic PD patients.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IRON;
RECOMBINANT ERYTHROPOIETIN;
TRANSFERRIN;
ADULT;
ANEMIA;
ARTICLE;
BLOOD;
CHRONIC KIDNEY FAILURE;
COMPARATIVE STUDY;
FEMALE;
HEMATOCRIT;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
PERITONEAL DIALYSIS;
PROSPECTIVE STUDY;
ADMINISTRATION, ORAL;
ADULT;
ANEMIA;
ERYTHROPOIETIN, RECOMBINANT;
FEMALE;
HEMATOCRIT;
HUMANS;
INFUSIONS, INTRAVENOUS;
IRON;
KIDNEY FAILURE, CHRONIC;
MALE;
MIDDLE AGED;
PERITONEAL DIALYSIS;
PROSPECTIVE STUDIES;
TRANSFERRIN;
|
|
EID: 0032222816
PISSN: 11978554
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
